Exploratory clinical trial on the safety and capability of dMD-001 in lumbar disc herniation: Study protocol for a first-in-human pilot study
Herniated nucleus pulposus (NP), one of the most common diseases of the spine, is surgically treated by removing the sequestered NP. However, intervertebral disc (IVD) defects may remain after discectomy, leading to inadequate tissue healing and predisposing patients to IVD degeneration. An acellula...
Main Authors: | Katsuhisa Yamada, Maeda Kenichiro, Yoichi M. Ito, Fujio Inage, Toshiyuki Isoe, Nozomi Yokota, Osamu Sugita, Norihiro Sato, Khin Khin Tha, Norimasa Iwasaki, Teruyo Arato, Hideki Sudo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Contemporary Clinical Trials Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S245186542100106X |
Similar Items
-
Biomaterials and Cell-Based Regenerative Therapies for Intervertebral Disc Degeneration with a Focus on Biological and Biomechanical Functional Repair: Targeting Treatments for Disc Herniation
by: Katsuhisa Yamada, et al.
Published: (2022-02-01) -
Protocol for treating lumbar spinal canal stenosis with a combination of ultrapurified, allogenic bone marrow-derived mesenchymal stem cells and in situ-forming gel: a multicentre, prospective, double-blind randomised controlled trial
by: Yoichi M Ito, et al.
Published: (2023-02-01) -
Injection of Ultra-Purified Stem Cells with Sodium Alginate Reduces Discogenic Pain in a Rat Model
by: Hisataka Suzuki, et al.
Published: (2023-02-01) -
Upward transtentorial herniation
by: Nidal B. Omar, et al.
Published: (2020-12-01) -
Combination of ultra-purified stem cells with an in situ-forming bioresorbable gel enhances intervertebral disc regeneration
by: Daisuke Ukeba, et al.
Published: (2022-02-01)